-
Signature
-
/s/ Jeffrey Farrow, Attorney-in-Fact
-
Stock symbol
-
TARS
-
Transactions as of
-
Aug 11, 2025
-
Transactions value $
-
-$300,000
-
Form type
-
4
-
Date filed
-
8/13/2025, 04:32 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Azamian Bobak R. |
President/CEO and Board Chair, Director |
C/O TARSUS PHARMACEUTICALS, INC., 15440 LAGUNA CANYON ROAD, SUITE 160, IRVINE |
/s/ Jeffrey Farrow, Attorney-in-Fact |
2025-08-13 |
0001827672 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
TARS |
Common Stock |
Sale |
-$300K |
-6K |
-0.73% |
$50.00 |
818K |
Aug 11, 2025 |
By the Bobak Azamian Living Trust established April 16, 2018 |
F1, F2 |
| holding |
TARS |
Common Stock |
|
|
|
|
|
53.6K |
Aug 11, 2025 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: